These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 30710469)

  • 21. Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS).
    Truong CB; Durham SH; Qian J
    Expert Opin Drug Saf; 2021 May; 20(5):603-609. PubMed ID: 33573405
    [No Abstract]   [Full Text] [Related]  

  • 22. Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
    Pogue JM; Jones RN; Bradley JS; Andes DR; Bhavnani SM; Drusano GL; Dudley MN; Flamm RK; Rodvold KA; Ambrose PG
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society.
    Liu X; Huang C; Bergen PJ; Li J; Zhang J; Chen Y; Chen Y; Guo B; Hu F; Hu J; Hu L; Li X; Qiu H; Shao H; Sun T; Wang Y; Xu P; Yang J; Yang Y; Yu Z; Zhang B; Zhu H; Zuo X; Zhang Y; Miao L; Zhang J
    J Zhejiang Univ Sci B; 2023 Feb; 24(2):130-142. PubMed ID: 36751699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin: understanding and applying recent pharmacokinetic advances.
    Ortwine JK; Kaye KS; Li J; Pogue JM
    Pharmacotherapy; 2015 Jan; 35(1):11-6. PubMed ID: 25187500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colistin and polymyxin B: peas in a pod, or chalk and cheese?
    Nation RL; Velkov T; Li J
    Clin Infect Dis; 2014 Jul; 59(1):88-94. PubMed ID: 24700659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 30. Rational Combinations of Polymyxins with Other Antibiotics.
    Bergen PJ; Smith NM; Bedard TB; Bulman ZP; Cha R; Tsuji BT
    Adv Exp Med Biol; 2019; 1145():251-288. PubMed ID: 31364082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
    Zavascki AP; Goldani LZ; Li J; Nation RL
    J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.
    Vardakas KZ; Falagas ME
    Int J Antimicrob Agents; 2017 Feb; 49(2):233-238. PubMed ID: 27686609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
    Zavascki AP
    Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.
    Ahmed MU; Velkov T; Lin YW; Yun B; Nowell CJ; Zhou F; Zhou QT; Chan K; Azad MAK; Li J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Use of Polymyxin B.
    Rigatto MH; Falci DR; Zavascki AP
    Adv Exp Med Biol; 2019; 1145():197-218. PubMed ID: 31364080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME; Kasiakou SK
    Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.